D017270Chemicals & DrugsD10.532.350D12.776.521.4006100.985607Lipoprotein(a)plugins:TwitterTwitterFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:pluginSearchableDataProfilesRNS Plugin Searchable Dataprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonWake Forest School of MedicineAlainBertoniAlain Bertoni MD, MPH36.09550200000000-80.243937000000008Bertoni, AlainProfessorParagChevli Parag A. Chevli MBBS36.08862300000000-80.268210999999991799Chevli , ParagAssociate ProfessorLauraCoxLaura A. Cox PhD36.09040200000000-80.267005999999992140Cox, LauraProfessor20ProfessorMichaelShapiroMichael D. Shapiro DO2451Shapiro, MichaelProfessor30354212Steffen BT, Duprez D, Bertoni AG, Guan W, Tsai MYArteriosclerosis, thrombosis, and vascular biologySteffen BT, Duprez D, Bertoni AG, Guan W, Tsai MY. Lp(a) [Lipoprotein(a)]-Related Risk of Heart Failure Is Evident in Whites but Not in Other Racial/Ethnic Groups. Arterioscler Thromb Vasc Biol. 2018 10; 38(10):2498-2504.Arterioscler Thromb Vasc Biol2018-10-01T00:00:002018Lp(a) [Lipoprotein(a)]-Related Risk of Heart Failure Is Evident in Whites but Not in Other Racial/Ethnic Groups.31130489Warden BA, Minnier J, Watts GF, Fazio S, Shapiro MDJournal of clinical lipidologyWarden BA, Minnier J, Watts GF, Fazio S, Shapiro MD. Impact of PCSK9 inhibitors on plasma lipoprotein(a) concentrations with or without a background of niacin therapy. J Clin Lipidol. 2019 Jul - Aug; 13(4):580-585.J Clin Lipidol2019-04-26T00:00:002019Impact of PCSK9 inhibitors on plasma lipoprotein(a) concentrations with or without a background of niacin therapy.28506388Edmiston JB, Brooks N, Tavori H, Minnier J, Duell B, Purnell JQ, Kaufman T, Wojcik C, Voros S, Fazio S, Shapiro MDJournal of clinical lipidologyEdmiston JB, Brooks N, Tavori H, Minnier J, Duell B, Purnell JQ, Kaufman T, Wojcik C, Voros S, Fazio S, Shapiro MD. Discordant response of low-density lipoprotein cholesterol and lipoprotein(a) levels to monoclonal antibodies targeting proprotein convertase subtilisin/kexin type 9. J Clin Lipidol. 2017 May - Jun; 11(3):667-673.J Clin Lipidol2017-03-09T00:00:002017Discordant response of low-density lipoprotein cholesterol and lipoprotein(a) levels to monoclonal antibodies targeting proprotein convertase subtilisin/kexin type 9.24Assistant ProfessorYashashwiPokharelYashashwi Pokharel MD, MSCR2582Pokharel, YashashwiAssistant Professor31043469Pokharel Y, Mouhanna F, Nambi V, Virani SS, Hoogeveen R, Alonso A, Heiss G, Coresh J, Mosley T, Gottesman RF, Ballantyne CM, Power MCNeurologyPokharel Y, Mouhanna F, Nambi V, Virani SS, Hoogeveen R, Alonso A, Heiss G, Coresh J, Mosley T, Gottesman RF, Ballantyne CM, Power MC. ApoB, small-dense LDL-C, Lp(a), LpPLA2 activity, and cognitive change. Neurology. 2019 05 28; 92(22):e2580-e2593.Neurology2019-05-01T00:00:002019ApoB, small-dense LDL-C, Lp(a), LpPLA2 activity, and cognitive change.28554015Agarwala A, Pokharel Y, Saeed A, Sun W, Virani SS, Nambi V, Ndumele C, Shahar E, Heiss G, Boerwinkle E, Konety S, Hoogeveen RC, Ballantyne CMAtherosclerosisAgarwala A, Pokharel Y, Saeed A, Sun W, Virani SS, Nambi V, Ndumele C, Shahar E, Heiss G, Boerwinkle E, Konety S, Hoogeveen RC, Ballantyne CM. The association of lipoprotein(a) with incident heart failure hospitalization: Atherosclerosis Risk in Communities study. Atherosclerosis. 2017 07; 262:131-137.Atherosclerosis2017-05-12T00:00:002017The association of lipoprotein(a) with incident heart failure hospitalization: Atherosclerosis Risk in Communities study.Internal Medicine, Cardiovascular MedicineInternal Medicine, HospitalistsInternal Medicine, Molecular MedicinePublic Health Sciences (Division of)Twitter Tweets Harvard Tweetstrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1ProfessorProfessor1.635650.01340026research area of0.7153740.045993213subject area for